Metastatic organotropism: a brief overview

Margarida Carrolo1, João A I Miranda2, Guilherme Vilhais1

  • 1Hematology and Oncology Department, CUF Oncologia, Lisbon, Portugal.

PubMed

Insights

Organotropism, the tendency for cancer to spread to specific organs, remains poorly understood. This review explores pre-metastatic niche formation, immune responses, and genetic changes driving organotropism and metastasis.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metastasis Research

Background:

  • Organotropism, the preferential spread of cancer to specific organs, has been recognized for over a century but its mechanisms remain largely elusive.
  • Metastasis is a complex process involving multiple steps, with organotropism playing a critical role in determining secondary tumor sites.
  • Understanding organotropism is crucial for developing effective cancer therapies and improving patient outcomes.

Purpose of the Study:

  • To provide a comprehensive overview of the current understanding of organotropism mechanisms.
  • To highlight the formation of the pre-metastatic niche, immune system interactions, and genomic alterations in organotropism.
  • To discuss the specific case of brain metastases and the implications of organotropism for cancer treatment.

Main Methods:

  • This mini-review synthesizes existing research on organotropism and metastasis.
  • It focuses on key aspects including pre-metastatic niche formation, immune surveillance, and genetic drivers.
  • Literature analysis covers established knowledge and recent findings in the field.

Main Results:

  • Organotropism is influenced by the formation of pre-metastatic niches that prepare distant organs for cancer cell colonization.
  • Immune defenses play a dual role, both inhibiting and facilitating metastasis depending on the context.
  • Genomic alterations in primary tumors contribute significantly to their organ-specific metastatic potential.

Conclusions:

  • A deeper comprehension of organotropism mechanisms is essential for effective metastasis management.
  • Targeting the pre-metastatic niche and modulating immune responses are potential therapeutic strategies.
  • Further research into the genetic underpinnings of organotropism is necessary to develop novel anti-metastatic treatments.